Richard Schlemmer

[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfato-platinum(II) — Pharmacokinetic Studies

Günther Bernhardt, Marion Koch, Thilo Spruß et al. · Archiv der Pharmazie · 1999 · 15 citations

Medicine, Oncology, Pharmacology +8

Establishment and Characterization of New Murine Breast Cancer Cell Lines

Günther Bernhardt, Karin Beckenlehner, Thilo Spruß et al. · Archiv der Pharmazie · 2002 · 12 citations

Medicine, Oncology, Pharmacology +13

[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers - Evidence for a Diethylstilbestrol-Like Mode of Action

Richard Schlemmer, Thilo Spruß, Günther Bernhardt et al. · Archiv der Pharmazie · 1999 · 12 citations

Medicine, Oncology, Pharmacology +11

1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes — New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2001 · 12 citations

Pharmacy, Medicinal Chemistry, Oncology +11

[1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug‐Target Interaction to the Antitumor Activity

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2004 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +17